| Isaiah J Fidler, DVM, PhD |
Present Title & Affiliation
Primary Appointment
Dual/Joint/Adjunct Appointment
Research Interests
Research in my laboratory continues to focus on the biology and therapy of cancer metastasis. Most recently, we have focused on the development and progression of brain metastasis. A large number of cancer patients develop metastasis to the brain. For untreated patients, the median survival is 1-2 months, and conventional radio-chemotherapy can extend the median survival to 4-6 months. The outcome of metastasis in general and brain metastasis in particular depends on the interaction of specific metastatic cells with host factors in the organ microenvironment (the “seed and soil” principle).
Histological examination of clinical specimens of human breast, lung, melanoma, and colon brain metastases demonstrates that the lesions are surrounded and infiltrated by activated astrocytes expressing glial fibrillary acidic protein (GFAP). GFAP-positive astrocytes are also associated with experimental brain metastases produced in mice by lung, brain, melanoma, and colon cancers. We isolated astrocytes from the brain of the “ImmortoMouse” and established the cells in culture. Multiple in vitro studies conclude that astrocytes cocultured with tumor cells protect the tumor cells from chemotherapeutic agents (Taxol, VCR, VBL, 5-FU). Establishment of a gap junction between astrocytes and tumor cells is required for this chemoprotection. Coculture of tumor cells with other tumor cells or fibroblasts does not protect the cells from chemotherapeutic drugs. Microarray experiments for cross-species hybridization (human tumor cells cocultured with mouse astrocytes or mouse fibroblasts) identified upregulation of survival genes in tumor cells cocultured with astrocytes, but not with fibroblasts. Significantly, these survival genes were uniformly upregulated in different tumor cells (breast, lung) cocultured with astrocytes.
The role of astrocytes in physiology is to supply glucose and oxygen to neurons to assure their survival. Unfortunately, tumor cells that can proliferate in the brain parenchyma exploit astrocytes for these same functions. Since the development of metastases depends on the interactions of tumor cells with host factors, treatment of brain metastasis must be directed against both the tumor cells and the organ microenvironment.
Education & Training
Degree-Granting Education | |
| 1970 | University of Pennsylvania, Philadelphia, PHD, Pathology |
| 1963 | Oklahoma State University, Stillwater, OK, DVM, Veterinary Medicine |
| 1961 | Oklahoma State University, Stillwater, OK, BS, Veterinary Medicine |
Experience/Service
Academic Appointments
Administrative Appointments/Responsibilities
Military or Other Governmental Service
Honors and Awards
| 2013 | ACS Medal of Honor in Basic Research Award, American Cancer Society |
| 2010-present | Annual I.J. "Josh" Fidler Innovation in Metastasis Research Award, Metastasis Research Society |
| 2010-present | Annual Isaiah J. Fidler Graduate Fellowship in Cancer Metastasis, GSBS |
| 2010 | Maimonides Award, State of Israel Bonds |
| 2010 | Nature Publishing Lifetime Achievement Award, Nature Publishing |
| 2009 | iSBTc Richard V. Smalley Memorial Lectureship Award, iSBTc |
| 2007 | AAAS Fellow, American Association for the Advancement of Science |
| 2004 | Charles A. LeMaistre Outstanding Achievement Award in Cancer, MDACC |
| 1999 | Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research |
| 1993 | City of Paris Medal of Vermeil |
| 1988 | G. H. A. Clowes Memorial Award |
Selected Publications
Peer-Reviewed Original Research Articles | ||
| 1. | Langley RR, Fidler IJ. The seed and soil hypothesis revisited - the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer 128(11):2527-2535, 6/1/2011. e-Pub 3/25/2011. PMCID: PMC3075088. | |
| 2. | Guo L, Langley RR, Fan D, Zhang F, Tsan R, Lee J-S, Fidler IJ. Selection of brain metastasis-initiating breast cancer cells according to growth on hard agar. American Journal of Pathology 178(5):2357-2366, 5/2011. | |
| 3. | Kim SJ, Kim JS, Park ES, Lee JS, Lin Q, Langley RR, Maya M, He J, Kim SW, Weihua Z, Balasubramanian K, Fan D, Mills GB, Hung MC, Fidler IJ. Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia 13(3):286-298, 3/2011. PMCID: PMC3050871. | |
| 4. | Kim SJ, Kim JS, Kim SW, Brantley E, Yun SJ, He J, Maya M, Zhang F, Wu Q, Lehembre F, Regenass U, Fidler IJ. Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer. Neoplasia 13(2):167-179, 2/2011. PMCID: PMC3033595. | |
| 5. | Tanaka T, Godin B, Bhavane R, Nieves-Alicea R, Gu J, Liu X, Chiappini C, Fakhoury JR, Amra S, Ewing A, Li Q, Fidler IJ, Ferrari M. In vivo Evaluation of Safety of Nanoporous Silicon Carriers Following Single and Multiple Dose Intravenous Administrations in Mice. Int J Pharm 402(1-2):190-197, 12/15/2010. e-Pub 9/29/2010. PMCID: PMC2982888. | |
| 6. | Fidler IJ, Balasubramanian K, Lin Q, Kim SW, Kim SJ. The brain microenvironment and cancer metastasis. Mol Cells 30(2):93-98, 8/2010. e-Pub 8/19/2010. PMID: 20799011. | |
| 7. | Kuo HP, Lee DF, Chen CT, Liu M, Chou CK, Lee HJ, Du Y, Xie X, Wei Y, Xia W, Weihua Z, Yang JY, Yen CJ, Huang TH, Tan M, Xing G, Zhao Y, Lin CH, Tsai SF, Fidler IJ, Hung MC. ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal 3(108):ra9, 2010. e-Pub 2/9/2010. PMCID: PMC2874891. | |
| 8. | Kim SJ, Kim JS, Papadopoulos J, Wook Kim S, Maya M, Zhang F, He J, Fan D, Langley R, Fidler IJ. Circulating macrophages expressing CD31: implications for acute and chronic angiogenesis. Am J Pathol 174(5):1972-1980, 5/2009. e-Pub 4/6/2009. PMCID: PMC2671284. | |
| 9. | Zhang C, Zhang F, Tsan R, Fidler IJ. Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. Cancer Res 69(3):828-835, 2/1/2009. e-Pub 1/13/2009. PMCID: PMC2633423. | |
| 10. | Weihua Z, Tsan R, Huang WC, Wu Q, Chiu CH, Fidler IJ, Hung MC. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 13(5):385-93, 5/2008. PMCID: PMC2413063. | |
| 11. | Weihua Z, Tsan R, Schroit AJ, Fidler IJ. Apoptotic cells initiate endothelial cell sprouting via electrostatic signaling. Cancer Res 65(24):11529-35, 12/2005. PMCID: PMC1404497. | |
| 12. | Fidler IJ. The organ microenvironment and cancer metastasis. Differentiation 70(9-10):498-505, 12/2002. PMID: 12492492. | |
| 13. | Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 50(19):6130-8, 10/1990. PMID: 1698118. | |
| 14. | Schackert G, Fidler IJ. Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals. Cancer Res 48(12):3478-84, 6/1988. PMID: 3370643. | |
| 15. | Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science 217(4564):998-1003, 9/1982. PMID: 7112116. | |
| 16. | Talmadge JE, Wolman SR, Fidler IJ. Evidence for the clonal origin of spontaneous metastases. Science 217(4557):361-3, 7/1982. PMID: 6953592. | |
| 17. | Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 197(4306):893-5, 8/1977. PMID: 887927. | |
| 18. | Fidler IJ. Selection of successive tumour lines for metastasis. Nat New Biol 242(118):148-9, 4/1973. PMID: 4512654. | |
| 19. | Fidler IJ. Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst 45(4):773-82, 10/1970. PMID: 5513503. | |
Invited Articles | ||
| 1. | Fidler IJ. Biologial heterogeneity of cancer -- implication to therapy (Commentary). Human Vaccines and Immunotherapeutics 8(8):1141-1142, 8/2012. | |
| 2. | Fidler IJ. The role of the organ microenvironment in brain metastasis. Semin Cancer Biol 21(2):107-112, 4/2011. e-Pub 12/16/2010. PMID: 21167939. | |
| 3. | Talmadge JE, Fidler IJ. AACR Centennial Series: The biology of cancer metastasis: historical perspective. Cancer Res 70(14):5649-5669, 7/15/2010. e-Pub 7/7/2010. PMID: 20610625. | |
Book Chapters | ||
| 1. | Fidler IJ, Kripke ML. The biology of cancer metastasis. In: Cancer - The Outlaw Cell, 3. Ed(s) LaFond R. Oxford University Press: New York, NY, 198-210, 2012. | |
Grant & Contract Support
| Title: | Therapy of Liver Metastases via Multi-stage System |
| Funding Source: | NIH/NCI |
| Role: | Project Leader |
| Principal Investigator: | Mauro Ferrari |
| Duration: | 9/28/2009 - 7/31/2014 |
| Title: | The Role of Endothelin in Progressive Growth and Metastasis of Neoplasms |
| Funding Source: | Actelion Pharmaceuticals, Ltd. |
| Role: | Principal Investigator |
| Duration: | 1/1/2008 - present |
Last updated: 3/4/2013
- Global Navigation
- About Us
- Locations
- Calendar
- Careers
- Publications
- How You Can Help
- Contact Us
- Newsroom
- Site Index
- Patient and Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children's Cancer Hospital
- Services & Amenities
- Education and Research
- Departments, Programs and Labs
- PeopleFinder
- Research at MD Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Alert Information
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
- Legal and Policy
- Legal Statements
- Site Policies
- Reporting Fraud, Waste & Abuse

